Posttranslational phosphorylation of mutant p53 protein in tumor development

Medical Molecular Morphology

Volumn 39, Issue 2, 2006, Pages 79-87

  Matsumoto, Manabu ^a   Furihata, Mutsuo ^b   Ohtsuki, Yuji ^b  

^a KOCHI MEDICAL SCHOOL HOSPITAL   (Japan)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

Kinase; Mutant; p53; Phosphorylation; Serine 15; Serine 392

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

APOPTOSIS; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONFERENCE PAPER; DNA REPLICATION; MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

HUMANS; MUTANT PROTEINS; NEOPLASMS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33750036122     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-006-0320-0     Document Type: Conference Paper

References (132)

1. AJ Levine J Momand CA Finlay 1991 The p53 tumour suppressor gene Nature (Lond) 351 453 456
2. SW Lowe EM Schmitt SW Smith BA Osborne T Jacks 1993 p53 is required for radiation-induced apoptosis in mouse thymocytes Nature (Lond) 362 847 849
3. LS Cox T Hupp CA Midgley DP Lane 1995 A direct effect of activated human p53 on nuclear DNA replication EMBO J 14 2099 2105
4. WS el-Deiry 1998 Regulation of p53 downstream genes Semin Cancer Biol 8 345 357
5. KH Vousden 2000 p53: death star Cell 103 691 694
6. AM Bode Z Dong 2004 Post-translational modification of p53 in tumorigenesis Nat Rev Cancer 4 793 805
7. DW Meek 1994 Post-transcriptional modification of p53 Semin Cancer Biol 5 203 210
8. C Prives 1998 Signaling to p53: breaking the MDM2-p53 circuit Cell 95 5 8
9. AJ Giaccia MB Kastan 1998 The complexity of p53 modulation: emerging patterns from divergent signals Genes Dev 12 2973 2983
10. K Sakaguchi H Sakamoto MS Lewis CW Anderson JW Erickson E Appella D Xie 1997 Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53 Biochemistry 36 10117 10124
11. M Ashcroft MH Kubbutat KH Vousden 1999 Regulation of p53 function and stability by phosphorylation Mol Cell Biol 19 1751 1758
12. SY Shieh M Ikeda Y Taya C Prives 1997 DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 Cell 91 325 334
13. WS El-Deiry SE Kern JA Pietenpol KW Kinzler B Vogelstein 1992 Definition of a consensus binding site for p53 Nat Genet 1 45 49
14. Y Cho S Gorina PD Jeffrey NP Pavletich 1994 Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations Science 265 346 355
15. SE Kern KW Kinzler A Bruskin D Jarosz P Friedman C Prives B Vogelstein 1991 Identification of p53 as a sequence-specific DNA-binding protein Science 252 1708 1711
16. C Cadwell GP Zambetti 2001 The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth Gene (Amst) 277 15 30
17. MG van Oijen PJ Slootweg 2000 Gain-of-function mutations in the tumor suppressor gene p53 Clin Cancer Res 6 2138 2145
18. SJ Ullrich K Sakaguchi SP Lees-Miller M Fiscella WE Mercer CW Anderson E Appella 1993 Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53 Proc Natl Acad Sci U S A 90 5954 5958
19. Y Nagata T Anan T Yoshida T Mizukami Y Taya T Fujiwara H Kato H Saya M Nakao 1999 The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association Oncogene 18 6037 6049
20. T Minamoto T Buschmann H Habelhah E Matusevich H Tahara AL Boerresen-Dale C Harris D Sidransky Z Ronai 2001 Distinct pattern of p53 phosphorylation in human tumors Oncogene 20 3341 3347
21. VO Melnikova AB Santamaria SV Bolshakov HN Ananthaswamy 2003 Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase Oncogene 22 5958 5966
22. DB Yap JK Hsieh S Zhong V Heath B Gusterson T Crook X Lu 2004 Ser392 phosphorylation regulates the oncogenic function of mutant p53 Cancer Res 64 4749 4754
23. M Isobe BS Emanuel D Givol M Oren CM Croce 1986 Localization of gene for human p53 tumour antigen to band 17p13 Nature (Lond) 320 84 85
24. OW [tmp] McBride D Merry D Givol 1986 The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13) Proc Natl Acad Sci U S A 83 130 134
25. C Miller T Mohandas D Wolf M Prokocimer V Rotter HP Koeffler 1986 Human p53 gene localized to short arm of chromosome 17 Nature (Lond) 319 783 784
26. T Soussi C Caron de Fromentel P May 1990 Structural aspects of the p53 protein in relation to gene evolution Oncogene 5 945 952
27. S Fields SK Jang 1990 Presence of a potent transcription activating sequence in the p53 protein Science 249 1046 1049
28. L Raycroft HY Wu G Lozano 1990 Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene Science 249 1049 1051
29. J Chen V Marechal AJ Levine 1993 Mapping of the p53 and mdm-2 interaction domains Mol Cell Biol 13 4107 4114
30. JD Oliner JA Pietenpol S Thiagalingam J Gyuris KW Kinzler B Vogelstein 1993 Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Nature (Lond) 362 857 860
31. E Seto A Usheva GP Zambetti J Momand N Horikoshi R Weinmann AJ Levine T Shenk 1992 Wild-type p53 binds to the TATA-binding protein and represses transcription Proc Natl Acad Sci U S A 89 12028 12032
32. X Liu CW Miller PH Koeffler AJ Berk 1993 The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription Mol Cell Biol 13 3291 3300
33. R Truant H Xiao CJ Ingles J Greenblatt 1993 Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein J Biol Chem 268 2284 2287
34. LJ Ko C Prives 1996 p53: puzzle and paradigm Genes Dev 10 1054 1072
35. AJ Levine 1997 p53, the cellular gatekeeper for growth and division Cell 88 323 331
36. ML Avantaggiati V Ogryzko K Gardner A Giordano AS Levine K Kelly 1997 Recruitment of p300/CBP in p53-dependent signal pathways Cell 89 1175 1184
37. DM Scolnick NH Chehab ES Stavridi MC Lien L Caruso E Moran SL Berger TD Halazonetis 1997 CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein Cancer Res 57 3693 3696
38. A Dutta JM Ruppert JC Aster E Winchester 1993 Inhibition of DNA replication factor RPA by p53 Nature (Lond) 365 79 82
39. Z He BT Brinton J Greenblatt JA Hassell CJ Ingles 1993 The transactivator proteins VP16 and GAL4 bind replication factor A Cell 73 1223 1232
40. A Jawhari S Boussert V Lamour RA Atkinson B Kieffer O Poch N Potier A van Dorsselaer D Moras A Poterszman 2004 Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis Biochemistry 43 14420 14430
41. D Sakamuro P Sabbatini E White GC Prendergast 1997 The polyproline region of p53 is required to activate apoptosis but not growth arrest Oncogene 15 887 898
42. KK Walker AJ Levine 1996 Identification of a novel p53 functional domain that is necessary for efficient growth suppression Proc Natl Acad Sci U S A 93 15335 15340
43. X Li P Coffino 1996 High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation J Virol 70 4509 4516
44. M Hollstein D Sidransky B Vogelstein CC Harris 1991 p53 mutations in human cancers Science 253 49 53
45. C Caron de Fromentel C Soussi 1992 TP53 tumor suppressor gene: a model for investigating human mutagenesis Genes Chromosomes Cancer 4 1 15
46. JR Jenkins P Chumakov C Addison HW Sturzbecher A Wade-Evans 1988 Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen J Virol 62 3903 3906
47. JM Ruppert B Stillman 1993 Analysis of a protein-binding domain of p53 Mol Cell Biol 13 3811 3820
48. S Gorina NP Pavletich 1996 Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2 Science 274 1001 1005
49. K Iwabuchi PL Bartel B Li R Marraccino S Fields 1994 Two cellular proteins that bind to wild-type but not mutant p53 Proc Natl Acad Sci U S A 91 6098 6102
50. Y Xu 2003 Regulation of p53 responses by post-translational modifications Cell Death Differ 10 400 403
51. S Kraiss A Quaiser M Oren M Montenarh 1988 Oligomerization of oncoprotein p53 J Virol 62 4737 4744
52. XW Wang W Vermeulen JD Coursen M Gibson SE Lupold K Forrester G Xu L Elmore H Yeh JH Hoeijmakers CC Harris 1996 The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway Genes Dev 10 1219 1232
53. Y Wang C Prives 1995 Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases Nature (Lond) 376 88 91
54. P May E May 1999 Twenty years of p53 research: structural and functional aspects of the p53 protein Oncogene 18 7621 7636
55. TR Hupp A Sparks DP Lane 1995 Small peptides activate the latent sequence-specific DNA binding function of p53 Cell 83 237 245
56. S Kaku A Albor M Kulesz-Martin 2001 Dissociation of DNA binding and in vitro transcriptional activities dependent on the C terminus of P53 proteins Biochem Biophys Res Commun 280 204 211
57. G Shaulsky N Goldfinger A Ben-Ze'ev V Rotter 1990 Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis Mol Cell Biol 10 6565 6577
58. J Momand GP Zambetti DC Olson D George AJ Levine 1992 The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 69 1237 1245
59. X Wu JH Bayle D Olson AJ Levine 1993 The p53-mdm-2 autoregulatory feedback loop Genes Dev 7 1126 1132
60. S Maheswaran S Park A Bernard JF Morris FJ Rauscher 3rd DE Hill DA Haber 1993 Physical and functional interaction between WT1 and p53 proteins Proc Natl Acad Sci U S A 90 5100 5104
61. WS El-Deiry T Tokino VE Velculescu DB Levy R Parsons JM Trent D Lin WE Mercer KW Kinzler B Vogelstein 1993 WAF1, a potential mediator of p53 tumor suppression Cell 75 817 825
62. M Nakanishi Y Kaneko H Matsushime K Ikeda 1999 Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein Biochem Biophys Res Commun 263 35 40
63. M Oren 2003 Decision making by p53: life, death and cancer Cell Death Differ 10 431 442
64. T Miyashita M Harigai M Hanada JC Reed 1994 Identification of a p53-dependent negative response element in the bcl-2 gene Cancer Res 54 3131 3135
65. M Murphy A Hinman AJ Levine 1996 Wild-type p53 negatively regulates the expression of a microtubule-associated protein Genes Dev 10 2971 2980
66. X Wu AJ Levine 1994 p53 and E2F-1 cooperate to mediate apoptosis Proc Natl Acad Sci U S A 91 3602 3606
67. TR Hupp DW Meek CA Midgley DP Lane 1992 Regulation of the specific DNA binding function of p53 Cell 71 875 886
68. SR Hall LE Campbell DW Meek 1996 Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation Nucleic Acids Res 24 1119 1126
69. GA Mayr M Reed P Wang Y Wang JF Schweds P Tegtmeyer 1995 Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation Cancer Res 55 2410 2417
70. EL Paley 1996 Phosphorylation of T antigen and p53 in carcinogen-treated SV40-transformed Chinese hamster cells Carcinogenesis (Oxf) 17 939 945
71. M Fiscella N Zambrano SJ Ullrich T Unger D Lin B Cho WE Mercer CW Anderson E Appella 1994 The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities Oncogene 9 3249 3257
72. T Crook NJ Marston EA Sara KH Vousden 1994 Transcriptional activation by p53 correlates with suppression of growth but not transformation Cell 79 817 827
73. A Gatti HH Li JA Traugh X Liu 2000 Phosphorylation of human p53 on Thr-55 Biochemistry 39 9837 9842
74. T Unger T Juven-Gershon E Moallem M Berger R Vogt Sionov G Lozano M Oren Y Haupt 1999 Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 EMBO J 18 1805 1814
75. L Qu S Huang D Baltzis AM Rivas-Estilla O Pluquet M Hatzoglou C Koumenis Y Taya A Yoshimura AE Koromilas 2004 Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta Genes Dev 18 261 277
76. MJ Waterman ES Stavridi JL Waterman TD Halazonetis 1998 ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins Nat Genet 19 175 178
77. DM Keller X Zeng Y Wang QH Zhang M Kapoor H Shu R Goodman G Lozano Y Zhao H Lu 2001 A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1 Mol Cell 7 283 292
78. H Lu RP Fisher P Bailey AJ Levine 1997 The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro Mol Cell Biol 17 5923 5934
79. DM Milne L [tmp] McKendrick LJ Jardine E Deacon JM Lord DW Meek 1996 Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate Oncogene 13 205 211
80. JR Bischoff PN Friedman DR Marshak C Prives D Beach 1990 Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2 Proc Natl Acad Sci U S A 87 4766 4770
81. SP Lees-Miller K Sakaguchi SJ Ullrich E Appella CW Anderson 1992 Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 Mol Cell Biol 12 5041 5049
82. J Baudier C Delphin D Grunwald S Khochbin JJ Lawrence 1992 Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein Proc Natl Acad Sci U S A 89 11627 11631
83. RT Abraham 2001 Cell cycle checkpoint signaling through the ATM and ATR kinases Genes Dev 15 2177 2196
84. LJ Ko SY Shieh X Chen L Jayaraman K Tamai Y Taya C Prives ZQ Pan 1997 p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner Mol Cell Biol 17 7220 7229
85. DL Persons EM Yazlovitskaya JC Pelling 2000 Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin J Biol Chem 275 35778 35785
86. N Dumaz DM Milne DW Meek 1999 Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15 FEBS Lett 463 312 316
87. V Adler MR Pincus T Minamoto SY Fuchs MJ Bluth PW Brandt-Rauf FK Friedman RC Robinson JM Chen XW Wang CC Harris Z Ronai 1997 Conformation-dependent phosphorylation of p53 Proc Natl Acad Sci U S A 94 1686 1691
88. DW Meek LE Campbell LJ Jardine U Knippschild L [tmp] McKendrick DM Milne 1997 Multi-site phosphorylation of p53 by protein kinases inducible by p53 and DNA damage Biochem Soc Trans 25 416 419
89. CE Helt WA Cliby PC Keng RA Bambara MA O'Reilly 2005 Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage J Biol Chem 280 1186 1192
90. R Araki R Fukumura A Fujimori Y Taya Y Shiloh A Kurimasa S Burma GC Li DJ Chen K Sato Y Hoki K Tatsumi M Abe 1999 Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells Cancer Res 59 3543 3546
91. GS Jimenez F Bryntesson MI Torres-Arzayus A Priestley M Beeche S Saito K Sakaguchi E Appella PA Jeggo GE Taccioli GM Wahl M Hubank 1999 DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage Nature (Lond) 400 81 83
92. SY Shieh J Ahn K Tamai Y Taya C Prives 2000 The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites Genes Dev 14 289 300
93. NH Chehab A Malikzay M Appel TD Halazonetis 2000 Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53 Genes Dev 14 278 288
94. SY Shieh Y Taya C Prives 1999 DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization EMBO J 18 1815 1823
95. T Unger T Juven-Gershon E Moallem M Berger R Vogt Sionov G Lozano M Oren Y Haupt 1999 Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 EMBO J 18 1805 1814
96. NH Chehab A Malikzay ES Stavridi TD Halazonetis 1999 Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage Proc Natl Acad Sci U S A 96 13777 13782
97. K Sakaguchi S Saito Y Higashimoto S Roy CW Anderson E Appella 2000 Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding J Biol Chem 275 9278 9283
98. E Appella CW Anderson 2001 Post-translational modifications and activation of p53 by genotoxic stresses Eur J Biochem 268 2764 2772
99. DV Bulavin S Saito MC Hollander K Sakaguchi CW Anderson E Appella AJ Fornace Jr 1999 Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation EMBO J 18 6845 6854
100. C Huang WY Ma A Maxiner Y Sun Z Dong 1999 p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389 J Biol Chem 274 12229 12235
101. K Oda H Arakawa T Tanaka K Matsuda C Tanikawa T Mori H Nishimori K Tamai T Tokino Y Nakamura Y Taya 2000 p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 Cell 102 849 862
102. T Buschmann O Potapova A Bar-Shira VN Ivanov SY Fuchs S Henderson VA Fried T Minamoto D Alarcon-Vargas MR Pincus WA Gaarde NJ Holbrook Y Shiloh Z Ronai 2001 Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress Mol Cell Biol 21 2743 2754
103. HH Li AG Li HM Sheppard X Liu 2004 Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression Mol Cell 13 867 878
104. Y Higashimoto S Saito XH Tong A Hong K Sakaguchi E Appella CW Anderson 2000 Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents J Biol Chem 275 23199 231203
105. T Buschmann V Adler E Matusevich SY Fuchs Z Ronai 2000 p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation Cancer Res 60 896 900
106. C Prives PA Hall 1999 The p53 pathway J Pathol 187 112 126
107. JP Blaydes MG Luciani S Pospisilova HM Ball B Vojtesek TR Hupp 2001 Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription J Biol Chem 276 4699 4708
108. GJ Milczarek J Martinez GT Bowden 1997 p53 Phosphorylation: biochemical and functional consequences Life Sci 60 1 11
109. M Hao AM Lowy M Kapoor A Deffie G Liu G Lozano 1996 Mutation of phosphoserine 389 affects p53 function in vivo J Biol Chem 271 29380 29385
110. TR Hupp DP Lane 1995 Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner J Biol Chem 270 18165 18174
111. M Matsumoto M Furihata A Kurabayashi Y Ohtsuki 2004 Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors Oncol Rep 12 1039 1043
112. M Matsumoto M Furihata A Kurabayashi S Sasaguri K Araki H Hayashi Y Ohtsuki 2004 Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma Oncology 67 143 150
113. M Furihata A Kurabayashi M Matsumoto H Sonobe Y Ohtsuki N Terao M Kuwahara T Shuin 2002 Frequent phosphorylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract J Pathol 197 82 88
114. PN Friedman X Chen J Bargonetti C Prives 1993 The p53 protein is an unusually shaped tetramer that binds directly to DNA Proc Natl Acad Sci USA 90 3319 3323
115. TD Halazonetis AN Kandil 1993 Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants EMBO J 12 5057 5064
116. JA Pietenpol T Tokino S Thiagalingam WS el-Deiry KW Kinzler B Vogelstein 1994 Sequence-specific transcriptional activation is essential for growth suppression by p53 Proc Natl Acad Sci USA 91 1998 2002
117. KG [tmp] McLure PW Lee 1998 How p53 binds DNA as a tetramer EMBO J 17 3342 3350
118. I Herskowitz 1987 Functional interaction of genes by dominant negative mutations Nature (Lond) 329 212 222
119. KV Chin K Ueda I Pastan MM Gottesman 1992 Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 Science 255 459 462
120. D Dittmer S Pati G Zambetti S Chu AK Teresky M Moore C Finlay AJ Levine 1993 Gain of function mutations in p53 Nat Genet 4 42 46
121. SP Deb RM Munoz DR Brown MA Subler S Deb 1994 Wild-type human p53 activates the human epidermal growth factor receptor promoter Oncogene 9 1341 1349
122. A Lanyi D Deb RC Seymour JH Ludes-Meyers MA Subler S Deb 1998 'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain Oncogene 16 3169 3176
123. MW Frazier X He J Wang Z Gu JL Cleveland GP Zambetti 1998 Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain Mol Cell Biol 18 3735 3743
124. X Yang A Pater SC Tang 1999 Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants Oncogene 18 4546 4553
125. RH Wenger M Gassmann 1997 Oxygen(es) and the hypoxia-inducible factor Biol Chem 378 609 616
126. ME Cockman N Masson DR Mole P Jaakkola GW Chang SC Clifford ER Maher CW Pugh PJ Ratcliffe PH Maxwell 2000 Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J Biol Chem 275 25733 25741
127. M Furihata H Sonobe Y Ohtsuki 1995 The aberrant p53 protein Int J Oncol 6 1209 1226
128. A Kanamoto H Kato Y Tachimori H Watanabe Y Nakanishi H Kondo H Yamaguchi T Gotoda K Muro Y Matsumura 1999 No prognostic significance of p53 expression in esophageal squamous cell carcinoma J Surg Oncol 72 94 98
129. M Sarbia R Porschen F Borchard O Horstmann R Willers HE Gabbert 1994 p53 protein expression and prognosis in squamous cell carcinoma of the esophagus Cancer (Phila) 74 2218 2223
130. T Tsujinaka H Shiozaki M Yamamoto M Inoue M Yano Y Doki M Monden 1999 Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma Am J Surg 177 503 506
131. M Gostissa A Hengstermann V Fogal P Sandy SE Schwarz M Scheffner G Del Sal 1999 Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1 EMBO J 18 6462 6471
132. P Shaw J Freeman R Bovey R Iggo 1996 Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus Oncogene 12 921 930